The University of Chicago Header Logo

Connection

Susan L. Cohn to Fenretinide

Back to Details
This is a "connection" page, showing publications Susan L. Cohn has written about Fenretinide.
Susan L. Cohn
Connection Strength
0.104
Fenretinide
  1. Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group. Clin Cancer Res. 2011 Nov 01; 17(21):6858-66.
    View in: PubMed
    Score: 0.104
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.